Jonathan Burgin

Jonathan Burgin

Directeur Général chez
BioCancell Therapeutics, Inc.
65 ans
Health Technology
Commercial Services
Technology Services

Profil

Jonathan Burgin's current job is as the Chief Executive Officer at BioCancell Therapeutics, Inc. He previously held positions as the Director-Investor Relations at XTL Biopharmaceuticals Ltd., Independent Director at Cellect Biotechnology Ltd., Chief Financial Officer at RADCOM Ltd., Chief Operating Officer at Anchiano Therapeutics Ltd., and Senior Manager at Kesselman & Kesselman.
Prior to these roles, he was a Member at PricewaterhouseCoopers International Ltd. and Chief Financial Officer at Y.L.R.
Capital Markets Ltd. Mr. Burgin obtained his undergraduate degree and MBA from Tel-Aviv University.

Postes actifs de Jonathan Burgin

SociétésPosteDébut
Directeur Général 04/06/2012

Anciens postes connus de Jonathan Burgin

SociétésPosteFin
ANCHIANO THERAPEUTICS LTD Directeur Général 19/10/2016
RADCOM LTD. Directeur Financier/CFO 21/05/2011
XTL BIOPHARMACEUTICALS LTD. Public Communications Contact 01/01/2006
Y.L.R. Capital Markets Ltd.
Directeur Financier/CFO 01/01/1999
Corporate Officer/Principal -
Voir l'expérience en détail de Jonathan Burgin

Formation de Jonathan Burgin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

46

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Technology Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Y.L.R. Capital Markets Ltd.

Health Technology

  1. Bourse
  2. Insiders
  3. Jonathan Burgin